Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands
- 1 May 2004
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 89-90, 437-441
- https://doi.org/10.1016/j.jsbmb.2004.03.013
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing CytokinesThe Journal of Experimental Medicine, 2002
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4Nature Immunology, 2002
- 1α,25-Dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplantsKidney International, 2002
- Vitamin D: its role and uses in immunology1The FASEB Journal, 2001
- Immunobiology of Dendritic CellsAnnual Review of Immunology, 2000
- Potent Inhibition of Dendritic Cell Differentiation and Maturation by Vitamin D AnalogsBiochemical and Biophysical Research Communications, 2000
- PREVENTION OF AUTOIMMUNE DESTRUCTION OF SYNGENEIC ISLET GRAFTS IN SPONTANEOUSLY DIABETIC NONOBESE DIABETIC MICE BY A COMBINATION OF AVITAMIN D3 ANALOG AND CYCLOSPORINE1Transplantation, 1998
- Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.Journal of Clinical Investigation, 1998
- 1,25-Dihydroxyvitamin D 3 Receptors in Human LeukocytesScience, 1983